Skip to main content
. 2004 Jan 26;2004(1):CD003545. doi: 10.1002/14651858.CD003545.pub2

2.22. Analysis.

2.22

Comparison 2 TRIFLUOPERAZINE versus TYPICAL ANTIPSYCHOTICS, Outcome 22 Adverse events: 5d‐i. Extrapyramidal ‐ subgroup analysis ‐ high vs low potency control groups ‐ any effect.